Top Voluntary Benefits Stories
Akorn falls as 2012 revenue forecast disappoints
By Peter WestermanGeneric drug maker Akorn Inc. said Tuesday its profit slipped 76 percent in the fourth quarter compared to a year earlier, when it sold off a joint venture.
